By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


KemPharm, Inc. 

7 Hawkeye Drive
Suite 103
North Liberty  Iowa  52317  U.S.A.
Phone: 319-665-2575 Fax: 319-665-2577


Company News
KemPharm (KMPH) Reports Second Quarter 2017 Results 8/11/2017 11:08:16 AM
KemPharm (KMPH) Announces Preliminary Results From KP415 Pharmacokinetic Single And Multiple Dose Trial 8/10/2017 11:54:34 AM
KemPharm (KMPH) Announces Publication Of Study Of Intranasal Abuse Of Hydrocodone Combination Products In Pharmacoepidemiology & Drug Safety 8/8/2017 8:48:21 AM
KemPharm (KMPH) To Report Second Quarter 2017 Results 8/1/2017 1:51:17 PM
KemPharm (KMPH) Strengthens ADHD Prodrug Pipeline With Development Of KP484, A New, Super-Extended Release ADHD Methylphenidate Product Candidate 6/28/2017 9:15:29 AM
KemPharm (KMPH) To Present Clinical Data For KP511, An Opioid Prodrug Candidate, At The International Conference On Opioids 6/9/2017 8:14:49 AM
KemPharm (KMPH) Announces Addition To Leadership Team 6/1/2017 11:17:36 AM
KemPharm (KMPH) Reports First Quarter 2017 Results 5/11/2017 1:08:56 PM
KemPharm (KMPH) To Report First Quarter 2017 Results 5/1/2017 11:07:30 AM
Unclear Whether FDA Took Into Account KemPharm (KMPH)'s Amendment Data in Rejecting Apadaz Application 6/14/2016 9:22:57 AM